See more : Safello Group AB (publ) (SFL.ST) Income Statement Analysis – Financial Results
Complete financial analysis of SS Innovations International, Inc. (SSII) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SS Innovations International, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Guotai Junan International Holdings Limited (1788.HK) Income Statement Analysis – Financial Results
- Nanoveu Limited (NNVUF) Income Statement Analysis – Financial Results
- Sileon AB (publ) (SILEON.ST) Income Statement Analysis – Financial Results
- Northern Star Resources Limited (NSTYY) Income Statement Analysis – Financial Results
- Hill Street Beverage Company Inc. (HSEEF) Income Statement Analysis – Financial Results
SS Innovations International, Inc. (SSII)
About SS Innovations International, Inc.
SS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.88M | 1.46M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 5.17M | 968.72K | 18.79K | 37.43K | 37.70K | 19.46K | 789.00 | 0.00 |
| Gross Profit | 713.45K | 489.59K | -18.79K | -37.43K | -37.70K | -19.46K | -789.00 | 0.00 |
| Gross Profit Ratio | 12.13% | 33.57% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 576.17K | 83.28K | 1.00K | 3.00K | 60.87K | 27.13K | 71.17K | 138.38K |
| General & Administrative | 20.81M | 6.09M | 1.41M | 1.10M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | -18.79K | -37.43K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 20.81M | 6.09M | 1.39M | 1.06M | 3.22M | 913.79K | 938.85K | 324.12K |
| Other Expenses | 0.00 | 279.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 21.38M | 6.17M | 1.39M | 1.07M | 3.28M | 940.92K | 1.01M | 462.49K |
| Cost & Expenses | 26.55M | 7.14M | 1.41M | 1.10M | 3.32M | 960.38K | 1.01M | 462.49K |
| Interest Income | 129.76K | 239.73K | 118.00 | 6.00 | 0.00 | 58.00 | 84.00 | 31.00 |
| Interest Expense | 523.36K | 162.00K | 0.00 | 1.06K | 0.00 | 0.00 | 27.00K | 22.52K |
| Depreciation & Amortization | 162.62K | 128.90K | 18.79K | 37.43K | 37.70K | 19.46K | 789.00 | 0.00 |
| EBITDA | -20.26M | -5.31M | -1.47M | -1.09M | -3.33M | -940.86K | -1.01M | -462.46K |
| EBITDA Ratio | -344.51% | -380.60% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -20.67M | -5.68M | -1.41M | -1.10M | -3.32M | -960.38K | -1.01M | -462.49K |
| Operating Income Ratio | -351.52% | -389.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -273.60K | 77.73K | -77.27K | -21.75K | -63.29K | 58.00 | -26.91K | -22.49K |
| Income Before Tax | -20.94M | -5.60M | -1.48M | -1.12M | -3.39M | -960.32K | -1.04M | -484.98K |
| Income Before Tax Ratio | -356.17% | -384.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 3.00 | -1.00 | -2.00 | -3.00 | 2.00 | 0.00 |
| Net Income | -20.94M | -5.60M | -1.48M | -1.12M | -3.39M | -960.32K | -1.04M | -484.98K |
| Net Income Ratio | -356.17% | -384.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.16 | -0.14 | -0.52 | -0.48 | -1.57 | -0.46 | -0.53 | -0.25 |
| EPS Diluted | -0.16 | -0.14 | -0.52 | -0.48 | -1.57 | -0.46 | -0.53 | -0.25 |
| Weighted Avg Shares Out | 128.45M | 40.88M | 2.85M | 2.34M | 2.15M | 2.09M | 1.95M | 1.92M |
| Weighted Avg Shares Out (Dil) | 128.45M | 40.88M | 2.85M | 2.34M | 2.15M | 2.09M | 1.95M | 1.92M |
SS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa
Pan African Medical Device Distributor Surgical Lab to place the SSi Mantra Surgical Robotic System in Healthcare Facilities across the African Continent Surgical Lab has Begun Registration of SSi Mantra in 27 African countries FORT LAUDERDALE, Fla., Dec. 26, 2023...
SS Innovations International SSi Mantra Robotic Surgical System Crosses 500 Successful Procedure Milestone
Company Founder and Chairman, Dr. Sudhir P. Srivastava performed complex heart surgery, while simultaneously, Dr. Sudhir K.
SS Innovations International SSi Mantra Robotic Surgical System Crosses 500 Successful Procedure Milestone
Company Founder and Chairman, Dr. Sudhir P. Srivastava performed complex heart surgery, while simultaneously, Dr. Sudhir K. Rawal, Medical Director for Rajiv Gandhi Cancer Institute, performed complex Urology Oncology surgery, marking 500 surgery milestone using the SSi Mantra Surgical Robotic...
SS Innovations Appoints Dr. Sonia Shokeen as Head of Quality and Regulatory Affairs
Dr. Shokeen brings over 15 years of medical device experience, including time spent at Johnson & Johnson FORT LAUDERDALE, FL, Oct. 30, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII),...
Argus Research Initiates Equity Report Coverage on SS Innovations International, Inc. (OTC: SSII)
NEW YORK , Oct. 16, 2023 /PRNewswire/ -- Argus Research, an independent investment research firm, has launched Equity Report coverage on SS Innovations International, Inc. (OTC: SSII) Click here to view Full Argus Equity Report Excerpts & Highlights from the...
SS Innovations Enters Licensing Agreement with Johns Hopkins University
Company's flagship SSi Mantra surgical robotic system now installed at the university's Baltimore campus FORT LAUDERDALE, FL, Oct. 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of...
SS Innovations Receives Regulatory Approvals from the Guatemala Ministry of Health
The Mantra Surgical Robotic System has been given the approval to be used for clinical use in Guatemala, marking the Company's first regulatory approval in Central America
SS Innovations Appoints Colin Eke to Lead Global Business Development
Mr. Eke brings more than 20 years' industry experience to the role, including time spent at Intuitive Surgical and CMR Surgical
Advancing Healthcare: The Promise of Robotic Cardiac Surgery
October 4, 2023 Introduction The landscape of healthcare is continually evolving, with groundbreaking technologies reshaping the way medical procedures are performed. One such revolutionary advancement is Robotic Cardiac Surgery, a cutting-edge technique that combines precision engineering and medical expertise to...
SS Innovations Launches Innovative Robotic Cardiac Surgery Program in India
“Every patient should have access to gold standard surgical care, and we believe that our cost-effective surgical robotic system is a key part of the solution.” Dr. Sudhir Srivastava, SS Innovations October 4, 2023 SS Innovations International, Inc.
Source: https://incomestatements.info
Category: Stock Reports